Search for: "Wyeth Pharmaceuticals, Incorporated" Results 1 - 20 of 44
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2024, 6:18 am by Second Circuit Civil Rights Blog
Wyeth Pharmaceuticals, Inc., 616 F.3d 134 (2d Cir. 2010), that a plaintiff is not required to prove the employer's articulated reason is false, and that the the plaintiff can prevail by showing that an unlawful factor (like sex, race, etc.) was a motivating factor, even "without proving that the employer's proffered explanation was not some part of the employer's motivation. [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
9 Nov 2015, 7:09 am
Back in 2009 – when the blog was still a Bexis/Herrmann operation – we wrote a catch-all punitive damages post entitled (oddly enough) “On Punitive Damages. [read post]
26 May 2015, 7:42 am
  This one addresses how to incorporate genetic variation into the design and implementation of clinical investigations. [read post]
15 Jan 2015, 9:57 am by Maureen Johnston
At its Conference on January 16, 2015, the Court will consider petitions seeking review of issues such as liability for a priest’s failure to report inappropriate sexual conduct, scope of the exhaustion requirement in a takings claim, the Heck v. [read post]
28 Nov 2013, 5:00 am
Wyeth Pharmaceuticals, Inc., 15 A.3d 909, 935 n.17 (Pa. [read post]
31 Oct 2013, 5:00 am
  The facts sound rather like Wyeth v. [read post]
26 Dec 2012, 11:15 am by Bexis
Novartis Pharmaceuticals Corp., 2012 U.S. [read post]
30 Mar 2012, 2:30 am
Bell originally filed her lawsuit on April 12, 2010 where she listed drug manufacturers Wyeth, Pfizer, Schwartz Pharma and Alaven Pharmaceuticals as defendants, but the defendants asked the judge for a summary judgment under the claim that Bell did not take Reglan, but metoclopramide. [read post]
4 Mar 2012, 9:02 am by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989)(“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
2 Sep 2010, 8:35 am by Stefanie Levine
Patent No. 5,623,600 owned by Trend Micro, Incorporated and entitled VIRUS DETECTION AND REMOVAL APPARATUS FOR COMPUTER NETWORKS. [read post]
27 Aug 2010, 2:41 pm by Bexis
Ortho Pharmaceutical Corp., 209 Cal. [read post]